• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质量作用定律预测的竞争性放射性配体结合动力学。

The kinetics of competitive radioligand binding predicted by the law of mass action.

作者信息

Motulsky H J, Mahan L C

出版信息

Mol Pharmacol. 1984 Jan;25(1):1-9.

PMID:6708928
Abstract

Although equilibrium competitive radioligand binding studies are often used to characterize hormone and neurotransmitter receptors, the kinetics of such experiments have not been extensively explored. The interactions of the radioligand and competitor with the receptors can be described by two differential equations which can be solved to yield a single equation describing the binding of the radioligand as a function of time. This equation has several applications: First, it can be used to simulate competitive binding reactions under defined conditions. Second, fitting experimental data to this equation allows one to determine the association and dissociation rate constants of the competing ligand, parameters that cannot be derived from equilibrium experiments. Furthermore, this method can be used to determine the KI of the competing drug from data acquired before equilibrium is reached. Third, mathematical analysis of the binding equation allowed us to answer two specific questions regarding the kinetics of competitive radioligand binding: how long such an incubation takes to equilibrate, and how the IC50 varies over time. The answers to these questions depended, to a large extent, on the relative values of the dissociation rate constants of the radioligand and competitor, which can be determined as noted above. When the competitor dissociates from the receptors more rapidly than the radioligand, the IC50 first decreases and then increases, but never has a value less than the KI. At low radioligand concentrations, equilibrium is reached in the same amount of time required of the radioligand to dissociate completely from the receptors as determined in an "off-rate experiment." At higher concentrations of radioligand this time is halved. When the competitor dissociates from the receptor more slowly than does the radioligand, then the time required to equilibrate depends only on the dissociation rate constant of the competitor, and the IC50 decreases over time.

摘要

尽管平衡竞争性放射性配体结合研究常用于表征激素和神经递质受体,但此类实验的动力学尚未得到广泛探索。放射性配体和竞争者与受体的相互作用可用两个微分方程来描述,求解这两个方程可得到一个描述放射性配体结合量随时间变化的单一方程。该方程有几个应用:第一,它可用于模拟特定条件下的竞争性结合反应。第二,将实验数据拟合到该方程可使人们确定竞争配体的结合和解离速率常数,这些参数无法从平衡实验中得出。此外,该方法可用于根据平衡达到之前获取的数据确定竞争药物的抑制常数(KI)。第三,对结合方程的数学分析使我们能够回答关于竞争性放射性配体结合动力学的两个具体问题:这样的孵育需要多长时间达到平衡,以及半数抑制浓度(IC50)如何随时间变化。这些问题的答案在很大程度上取决于放射性配体和竞争者解离速率常数的相对值,如上文所述,这些值是可以确定的。当竞争者从受体上解离的速度比放射性配体快时,IC50先降低然后升高,但从未低于KI值。在低放射性配体浓度下,达到平衡所需的时间与在“解离速率实验”中确定的放射性配体从受体上完全解离所需的时间相同。在较高的放射性配体浓度下,这个时间减半。当竞争者从受体上解离的速度比放射性配体慢时,达到平衡所需的时间仅取决于竞争者的解离速率常数,且IC50随时间降低。

相似文献

1
The kinetics of competitive radioligand binding predicted by the law of mass action.质量作用定律预测的竞争性放射性配体结合动力学。
Mol Pharmacol. 1984 Jan;25(1):1-9.
2
Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.同时测量离体药物受体占有率和解离速率的分析方法:应用于(R)-二甲茚定对中枢组胺H1受体的占有率
J Recept Signal Transduct Res. 2009;29(2):84-93. doi: 10.1080/10799890902721339.
3
Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin.芳烃受体-配体结合的动力学和平衡研究:[125I]2-碘-7,8-二溴二苯并对二恶英的应用
Mol Pharmacol. 1988 Aug;34(2):229-37.
4
Characterization of Kinetic Binding Properties of Unlabeled Ligands via a Preincubation Endpoint Binding Approach.通过预孵育终点结合法对未标记配体的动力学结合特性进行表征。
J Biomol Screen. 2016 Aug;21(7):729-37. doi: 10.1177/1087057116652065. Epub 2016 Jun 7.
5
Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.竞争结合试验中的配体解离常数:与配体耗竭相关的误差
Mol Pharmacol. 1987 Jun;31(6):603-9.
6
The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.协同性对解离常数测定的影响:对程-普鲁索夫方程、斯卡查德分析、希尔分析及相关幂方程的考察
Pharmacol Res. 2004 Jul;50(1):21-40. doi: 10.1016/j.phrs.2003.11.007.
7
The pharmacological basis of receptor binding.受体结合的药理学基础。
Wien Klin Wochenschr. 1991;103(15):438-42.
8
In vitro receptor binding assays: general methods and considerations.体外受体结合试验:一般方法与注意事项。
Q J Nucl Med Mol Imaging. 2008 Sep;52(3):245-53. Epub 2008 May 13.
9
Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.使用放射性配体结合和药理学无效方法估算变构配体的亲和力。
Mol Pharmacol. 1988 Feb;33(2):187-94.
10
Scintillation proximity assay as a high-throughput method to identify slowly dissociating nonpeptide ligand binding to the GnRH receptor.闪烁邻近分析法作为一种高通量方法,用于鉴定与促性腺激素释放激素(GnRH)受体结合的缓慢解离非肽配体。
J Biomol Screen. 2007 Mar;12(2):235-9. doi: 10.1177/1087057106297362. Epub 2007 Jan 4.

引用本文的文献

1
Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics.绝热偏置分子动力学模拟揭示突变对毒蕈碱拮抗剂解离动力学的影响。
J Chem Inf Model. 2025 Jul 14;65(13):7129-7142. doi: 10.1021/acs.jcim.5c00601. Epub 2025 Jun 16.
2
Decoding ultrasensitive self-assembly of the calcium-regulated cytoskeletal protein Tcb2 using optical actuation.利用光驱动解码钙调节细胞骨架蛋白Tcb2的超敏自组装。
bioRxiv. 2025 May 29:2025.05.26.656216. doi: 10.1101/2025.05.26.656216.
3
Inhibition of ENT1 relieves intracellular adenosine-mediated T cell suppression in cancer.
ENT1的抑制可缓解癌症中细胞内腺苷介导的T细胞抑制。
Nat Immunol. 2025 May 12. doi: 10.1038/s41590-025-02153-3.
4
A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assay.一种通用的大麻素CB1和CB2受体时间分辨荧光共振能量转移动力学配体结合测定法。
Front Pharmacol. 2025 Apr 9;16:1469986. doi: 10.3389/fphar.2025.1469986. eCollection 2025.
5
Characterization of the Two-Domain Peptide Binding Mechanism of the Human CGRP Receptor for CGRP and the Ultrahigh Affinity ssCGRP Variant.人降钙素基因相关肽(CGRP)受体对CGRP及超高亲和力单链CGRP变体的双结构域肽结合机制的表征
Biochemistry. 2025 Apr 15;64(8):1770-1787. doi: 10.1021/acs.biochem.4c00812. Epub 2025 Apr 2.
6
Prolonged signaling of backbone-modified glucagon-like peptide- analogues with diverse receptor trafficking.具有不同受体转运的骨架修饰胰高血糖素样肽类似物的延长信号传导
Proc Natl Acad Sci U S A. 2025 Apr 8;122(14):e2407574122. doi: 10.1073/pnas.2407574122. Epub 2025 Apr 1.
7
Modulating the Kinetics of a Fluorescence Anisotropy Immunoassay Using Tracer Point Mutations to Measure Human C-Peptide Secretion On-Chip.利用示踪剂点突变调节荧光各向异性免疫测定动力学以在芯片上测量人C肽分泌
ACS Omega. 2025 Mar 13;10(11):11595-11606. doi: 10.1021/acsomega.5c00761. eCollection 2025 Mar 25.
8
Probing the Histamine H Receptor Binding Site to Explore Ligand Binding Kinetics.探究组胺H受体结合位点以探索配体结合动力学。
J Med Chem. 2025 Jan 9;68(1):448-464. doi: 10.1021/acs.jmedchem.4c02043. Epub 2024 Dec 26.
9
Ligand binding kinetics to evaluate the function and stability of AR in nanodiscs.用于评估纳米圆盘内雄激素受体功能和稳定性的配体结合动力学
Biophys J. 2025 Jan 21;124(2):440-457. doi: 10.1016/j.bpj.2024.12.018. Epub 2024 Dec 17.
10
Simplified Method for Kinetic and Thermodynamic Screening of Cardiotonic Steroids through the K-Dependent Phosphatase Activity of Na/K-ATPase with Chromogenic pNPP Substrate.通过色原性 pNPP 底物对 Na/K-ATPase 的 K 依赖性磷酸酶活性进行强心甾体的动力学和热力学筛选的简化方法。
Mol Pharmacol. 2024 Oct 17;106(5):225-239. doi: 10.1124/molpharm.124.000934.